Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Men are increasingly removing body hair for looks and cleanliness, and while hair loss can cause distress, it doesn't affect their self-esteem as much as it does in women.

Menopause often causes hair changes, and many women need better support and information.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Injecting CD34+ cell-containing platelet-rich plasma into the scalp can improve hair count and thickness in people with pattern hair loss.

Healthy women tend to lose more hair in July and April, and the least in February.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Zinc levels are not directly linked to pattern hair loss.

Microneedling may be an effective treatment for pattern hair loss.

Mesotherapy might help with hair loss but more research is needed.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Different hair loss patterns may be linked to varying male hormone levels.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

A new tool helps tailor treatments for hair loss in Type 2 Diabetes patients by considering gender differences in nutrient levels.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

Many in Saudi Arabia experience early hair loss but lack awareness of treatments.

Moderately high prolactin levels do not cause hair loss in women.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

A growth factor cocktail with FGF9 and microneedling effectively increases hair density and diameter in hair loss patients.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Finasteride may help treat hair loss in postmenopausal women.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

High androgen levels cause skin issues in PCOS, affecting quality of life.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.